Proteomics International Laboratories Ltd (ASX:PIQ) Bell Potter Healthcare Conference 2024 Investor Presentation

11/19/2024 11:34:13 PM

(MENAFN- ABN Newswire)

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the presentation to be provided by Dr Richard Lipscombe today to attendees of the Bell Potter Healthcare conference 2024.
*To view the presentation, please visit:
-p alt="Proteomics International Laboratories Ltd" src="https://media.abnnewswire.net/images/logos/37153en.png" style="float:left; height:15px; margin:5px; width:120px" />Proteomics International Laboratories (ASX:PIQ) is a wholly owned subsidiary and trading name of PILL, a medical technology company at the forefront of predictive diagnostics and bioanalytical services. The Company specialises in the area of proteomics - the industrial scale study of the structure and function of proteins. Proteomics International's mission is to improve the quality of lives by the creation and application of innovative tools that enable the improved treatment of disease.

Dr Richard Lipscombe Managing Director Proteomics International Laboratories Ltd T: +61 8 9389 1992 E: ... Dirk van Dissel Investor Relations & Corporate Advisor Candour Advisory T: +61 408 326 367 E: ... Andrew Williams Public Relations Profile Media T: +61 412 614 125 E: ...

MENAFN19112024000111011020ID1108904537

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.